Identification of Rigosertib for the Treatment of Recessive Dystrophic Epidermolysis Bullosa–Associated Squamous Cell Carcinoma

PURPOSE: Squamous cell carcinoma (SCC) of the skin is the leading cause of death in patients with the severe generalized form of the genetic disease recessive dystrophic epidermolysis bullosa (RDEB). Although emerging data are identifying why patients suffer this fatal complication, therapies for tr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cancer Res
Main Authors: Atanasova, Velina S., Pourreyron, Celine, Farshchian, Mehdi, Lawler, Michael, Brown, Christian A., Watt, Stephen A., Wright, Sheila, Warkala, Michael, Guttmann-Gruber, Christina, Hofbauer, Josefina Piñón, Fuentes, Ignacia, Prisco, Marco, Rashidghamat, Elham, Has, Cristina, Salas-Alanis, Julio C., Palisson, Francis, Hovnanian, Alain, McGrath, John A., Mellerio, Jemima E., Bauer, Johann W., South, Andrew P.
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8185613/
https://ncbi.nlm.nih.gov/pubmed/30846478
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-18-2661
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados